Spine and Brain Stimulation for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new therapy to help individuals with spinal cord injuries regain movement in their arms and hands. Researchers aim to determine if combining electrical stimulation of the upper spine and brain can enhance arm and hand function. Participants will undergo a combination of epidural spinal cord stimulation and paired spine and brain stimulation over 29 days. The trial seeks individuals who have had a spinal cord injury for more than a year and retain some arm movement. As an unphased trial, it offers participants the chance to contribute to groundbreaking research that could lead to new treatments for spinal cord injuries.
Will I have to stop taking my current medications?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are on medications that lower the seizure threshold, you may need to stop those to participate.
What prior data suggests that this method is safe for improving arm and hand function after spinal cord injury?
Research has shown that epidural spinal cord stimulation (eSCS) is generally safe, similar to its use for treating chronic pain, meaning most people tolerate it well. One study found that using eSCS for spinal cord injuries did not cause more side effects than expected, including effects on movement and other functions.
Another study examined the long-term effects and also found eSCS to be safe, identifying no major safety issues over time. While the treatment aims to improve movement in the arms and hands, current evidence suggests it is safe for people with spinal cord injuries.12345Why are researchers excited about this trial?
Unlike the standard of care for spinal cord injuries, which often includes physical therapy and medications to manage symptoms, epidural spinal cord stimulation offers a more direct approach by targeting the spinal cord itself. This technique involves placing electrodes on the spinal cord to stimulate nerve activity, potentially enhancing motor functions and providing more immediate improvements. Researchers are excited about this treatment because it pairs stimulation with structured rehabilitation, which may accelerate recovery and improve outcomes significantly compared to traditional methods. This innovative approach could offer new hope for those with spinal cord injuries, paving the way for faster and more effective rehabilitation.
What evidence suggests that this trial's treatments could be effective for improving arm and hand function after cervical spinal cord injury?
Research has shown that epidural spinal cord stimulation, which participants in this trial may receive, can significantly improve movement in people with spinal cord injuries. In one study, 44% of participants could take steps with assistance or independently, or stand up, and 87% demonstrated some improvement in movement. Another treatment option in this trial is paired spine and brain stimulation. Studies suggest that using spine and brain stimulation together can enhance movement by creating lasting changes in nerve pathways. This combined method has shown promise in improving movement and muscle control. Both treatments in this trial aim to help people regain use of their arms and hands after spinal cord injuries.45678
Who Is on the Research Team?
Jason B. Carmel, MD, PhD
Principal Investigator
Columbia University
Are You a Good Fit for This Trial?
This trial is for English-speaking adults over 18 with incomplete traumatic spinal cord injury between C4 to T1, who have some motor power in at least one upper extremity muscle group. Participants must be able to understand and follow instructions and consent to the study. Exclusions include a history of suicide attempts, ongoing ventilator use, certain metal implants or brain stimulators, severe psychiatric disorders, substance abuse affecting seizure risk, pregnancy plans during the study period, specific medical conditions or treatments that could interfere with the trial.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo temporary placement of cervical epidural spinal cord stimulation (SCS) electrodes and participate in a series of experiments over 29 days to study the effects of SCS and brain stimulation on arm and hand function.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments of adverse events and tolerability.
What Are the Treatments Tested in This Trial?
Interventions
- Epidural Spinal Cord Stimulation
- Paired Spine and Brain Stimulation
Trial Overview
The trial tests whether combining cervical spinal cord stimulation (electrical wires implanted near the spine) with transcranial magnetic brain stimulation can improve arm and hand function after an upper spinal cord injury. Over 29 days, experiments will assess if this dual approach offers functional benefits.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will undergo temporary placement of cervical epidural spinal cord stimulation (SCS) electrodes. They will undergo 2 visits of stimulation optimization based on mapping of motor responses to SCS and clinical assessments at a range of SCS parameters. Once a stimulation plan has been established, subjects will undergo baseline assessments with and without SCS over 2 visits. Subjects will then undergo 15 days of continuous SCS in conjunction with structured rehabilitation with occupational therapy. On each day of therapeutic stimulation, subjects will receive two sessions of SCS plus structured rehabilitation (for up to 1.5 hours per session). Subjects will undergo a clinical assessment with and without stimulation at the midpoint of the therapeutic stimulation period. After this therapeutic stimulation period, subjects will undergo 2 days of repeat assessments.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jason Carmel
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Published Research Related to This Trial
Citations
Epidural Spinal Cord Stimulation for Spinal Cord Injury in ...
Results indicated significant improvements in motor function: 44% of patients achieved assisted or independent stepping or standing; 87% showed ...
Spinal Cord Stimulation Research in the Restoration of ...
Motor recovery was the most common primary outcome for epidural and transcutaneous SCS studies, whereas bowel and bladder outcomes were most common for magnetic ...
Non-invasive spinal cord electrical stimulation for arm and ...
These results demonstrate the safety and efficacy of ARC EX Therapy to improve hand and arm functions in people living with cervical SCI.
A Review of Functional Restoration From Spinal Cord ...
This review aims to assess the efficacy of spinal cord stimulation, both epidural (eSCS) and transcutaneous (tSCS), on the return of function in individuals ...
Epidural Electrical Stimulation for Functional Recovery in ...
This study confirms the promising therapeutic effects of EES in SCI. EES combined with PT provides a potential approach for functional recovery in patients ...
The safety of epidural spinal cord stimulation to restore ...
Conclusions: eSCS to restore autonomic and volitional motor function following SCI has a similar safety profile as when used to treat chronic pain, despite the ...
Long-term Follow-up for Epidural Stimulation in SCI
The goal of this study is to understand long-term effects of spinal cord stimulation in individuals who have a spinal cord injury. The main aims are to: provide ...
Epidural Spinal Cord Stimulation for Spinal Cord Injury in ...
This study reviews the evolving role of epidural spinal cord stimulation (eSCS) in treating chronic SCI, focusing on its efficacy and safety.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.